PAHC FY 2023 Earnings Report — Phibro Animal Health Corporation Revenue & Financial Results | Market Cap Arena

Phibro Animal Health CorporationPAHC

FY 2023 Earnings

Reported August 30, 2023

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2023	Prior Q	FY 2022	QoQ Change	YoY Change
Revenue	$978M	—	$942M	—	3.8%
Op. Income	$72M	—	$79M	—	-9.0%
Gross Margin	30.5%	—	30.3%	—	0.2pp
Net Margin	3.3%	—	5.2%	—	-1.9pp
EPS (Diluted)	$0.81	—	$1.21	—	-33.1%
Free Cash Flow	-$38M	—	-$5M	—	-613.3%

Revenue Flow

Item	Amount
REVENUE	$978M
Cost of Revenue	$680M
GROSS PROFIT	$298M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$226M
Other Expenses	$0
Operating Expenses	$226M
Cost & Expenses	$906M
OPERATING INCOME	$72M
Interest Income	$3M
Interest Expense	$18M
Other Income/Expenses	-$18M
INCOME BEFORE TAX	$54M
Income Tax Expense	$21M
Net Income from Continuing Ops	$33M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$33M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$33M
D&A	$34M
EBIT	$72M
EBITDA	$106M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$978M
Cost of Revenue	$680M
GROSS PROFIT	$298M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$226M
Other Expenses	$0
Operating Expenses	$226M
Cost & Expenses	$906M
OPERATING INCOME	$72M
Interest Income	$3M
Interest Expense	$18M
Other Income/Expenses	-$18M
INCOME BEFORE TAX	$54M
Income Tax Expense	$21M
Net Income from Continuing Ops	$33M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$33M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$33M
D&A	$34M
EBIT	$72M
EBITDA	$106M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$33M
Depreciation & Amortization	$34M
Stock-Based Compensation	$0
Deferred Income Tax	-$3M
Other Non-Cash Items	-$9M
Change in Working Capital	-$41M
OPERATING CASH FLOW	$13M
Capital Expenditure	-$52M
Acquisitions (Net)	$0
Purchases of Investments	-$40M
Sales/Maturities of Investments	$17M
Other Investing Activities	$776.0K
NET CASH FROM INVESTING	-$74M
Net Debt Issuance	$43M
Common Stock Repurchased	$0
Common Dividends Paid	-$19M
Other Financing Activities	$4M
NET CASH FROM FINANCING	$27M
FREE CASH FLOW	-$38M
Net Change in Cash	-$33M

Balance Sheet

Item	Amount
Cash & Equivalents	$41M
Short-Term Investments	$40M
Net Receivables	$163M
Inventory	$278M
Other Current Assets	$63M
TOTAL CURRENT ASSETS	$586M
PP&E (Net)	$231M
Goodwill	$53M
Intangible Assets	$55M
Long-Term Investments	$11M
Tax Assets	$9M
Other Non-Current Assets	$26M
TOTAL NON-CURRENT ASSETS	$386M
TOTAL ASSETS	$971M
Account Payables	$74M
Short-Term Debt	$22M
Deferred Revenue	$0
Other Current Liabilities	$48M
TOTAL CURRENT LIABILITIES	$176M
Long-Term Debt	$453M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$12M
Other Non-Current Liabilities	$19M
TOTAL NON-CURRENT LIABILITIES	$513M
TOTAL LIABILITIES	$689M
Common Stock	$4.0K
Additional Paid-In Capital	$136M
Retained Earnings	$261M
Treasury Stock	$0
Accum. Other Comp. Income	-$114M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$283M
Minority Interest	$0
TOTAL EQUITY	$283M
TOTAL LIABILITIES & EQUITY	$971M
Total Debt	$510M
Net Debt	$469M